Cleft palate in a multigenerational family with a microdeletion of 20p12.3 involving BMP2

American Journal of Medical Genetics, Part A

Volumn 158 A, Issue 10, 2012, Pages 2616-2620

  Williams, Eli S ^a   Uhas, Kim A ^b   Bunke, Brian P ^a   Garber, Kathryn B ^a   Martin, Christa L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Judson Hawk Multispecialty and Craniofacial Clinics   (United States)

Author keywords

20p12.3; BMP2; Cleft palate; Microarray analysis; Microdeletion

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; GENOMIC DNA;

ARTICLE; BONE MORPHOGENETIC PROTEIN 2 GENE; CHILD; CHROMOSOME 20P; CHROMOSOME DELETION; CHROMOSOME MICRODELETION; CLEFT PALATE; CLINICAL ARTICLE; DEVELOPMENTAL DISORDER; ECHOCARDIOGRAPHY; FACE DYSMORPHIA; FAILURE TO THRIVE; FAMILY HISTORY; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENOME SIZE; HAPLOINSUFFICIENCY; HUMAN; JAW MALFORMATION; LANGUAGE DISABILITY; MALE; MICROARRAY ANALYSIS; MOTOR RETARDATION; PALPEBRAL FISSURE ANOMALY; PATENT DUCTUS ARTERIOSUS; PENETRANCE; PHENOTYPE; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; QT PROLONGATION; TOE MALFORMATION; WOLFF PARKINSON WHITE SYNDROME;

ADULT; AGED; BONE MORPHOGENETIC PROTEIN 2; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 20; CLEFT PALATE; FAMILY; FEMALE; HUMANS; MALE;

EID: 84866508403     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35594     Document Type: Article

References (24)

1. Anad F, Burn J, Matthews D, Cross I, Davison BC, Mueller R, Sands M, Lillington DM, Eastham E. 1990. Alagille syndrome and deletion of 20p. J Med Genet 27: 729-737.
2. Baldwin EL, Lee JY, Blake DM, Bunke BP, Alexander CR, Kogan AL, Ledbetter DH, Martin CL. 2008. Enhanced detection of clinically relevant genomic imbalances using a targeted plus whole genome oligonucleotide microarray. Genet Med 10: 415-429.
3. Barlow AJ, Francis-West PH. 1997. Ectopic application of recombinant BMP-2 and BMP-4 can change patterning of developing chick facial primordia. Development 124: 391-398.
4. Bragdon B, Moseychuk O, Saldanha S, King D, Julian J, Nohe A. 2011. Bone morphogenetic proteins: A critical review. Cell Signal 23: 609-620.
5. Croen LA, Shaw GM, Wasserman CR, Tolarova MM. 1998. Racial and ethnic variations in the prevalence of orofacial clefts in California, 1983-1992. Am J Med Genet 79: 42-47.
6. Furuta Y, Piston DW, Hogan BL. 1997. Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development. Development 124: 2203-2212.
7. Genisca AE, Frias JL, Broussard CS, Honein MA, Lammer EJ, Moore CA, Shaw GM, Murray JC, Yang W, Rasmussen SA. 2009. Orofacial clefts in the National Birth Defects Prevention Study, 1997-2004. Am J Med Genet Part A 149A: 1149-1158.
8. Jones MC. 1988. Etiology of facial clefts: Prospective evaluation of 428 patients. Cleft Palate J 25: 16-20.
9. Jones JM, Morrell JC, Gould SJ. 2000. Identification and characterization of HAOX1, HAOX2, and HAOX3, three human peroxisomal 2-hydroxy acid oxidases. J Biol Chem 275: 12590-12597.
10. Kamath BM, Thiel BD, Gai X, Conlin LK, Munoz PS, Glessner J, Clark D, Warthen DM, Shaikh TH, Mihci E, Piccoli DA, Grant SF, Hakonarson H, Krantz ID, Spinner NB. 2009. SNP array mapping of chromosome 20p deletions: Genotypes, phenotypes, and copy number variation. Hum Mutat 30: 371-378.
11. Kurian MA, Meyer E, Vassallo G, Morgan NV, Prakash N, Pasha S, Hai NA, Shuib S, Rahman F, Wassmer E, Cross JH, O'Callaghan FJ, Osborne JP, Scheffer IE, Gissen P, Maher ER. 2010. Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy. Brain 133: 2964-2970.
12. Lalani SR, Thakuria JV, Cox GF, Wang X, Bi W, Bray MS, Shaw C, Cheung SW, Chinault AC, Boggs BA, Ou Z, Brundage EK, Lupski JR, Gentile J, Waisbren S, Pursley A, Ma L, Khajavi M, Zapata G, Friedman R, Kim JJ, Towbin JA, Stankiewicz P, Schnittger S, Hansmann I, Ai T, Sood S, Wehrens XH, Martin JF, Belmont JW, Potocki L. 2009. 20p12.3 microdeletion predisposes to Wolff-Parkinson-White syndrome with variable neurocognitive deficits. J Med Genet 46: 168-175.
13. Le Gloan L, Pichon O, Isidor B, Boceno M, Rival JM, David A, Le Caignec C. 2008. A 8.26Mb deletion in 6q16 and a 4.95Mb deletion in 20p12 including JAG1 and BMP2 in a patient with Alagille syndrome and Wolff-Parkinson-White syndrome. Eur J Med Genet 51: 651-657.
14. Lim DA, Tramontin AD, Trevejo JM, Herrera DG, Garcia-Verdugo JM, Alvarez-Buylla A. 2000. Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron 28: 713-726.
15. Lyons KM, Pelton RW, Hogan BL. 1990. Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). Development 109: 833-844.
16. Mabie PC, Mehler MF, Kessler JA. 1999. Multiple roles of bone morphogenetic protein signaling in the regulation of cortical cell number and phenotype. J Neurosci 19: 7077-7088.
17. Nakashima K, Takizawa T, Ochiai W, Yanagisawa M, Hisatsune T, Nakafuku M, Miyazono K, Kishimoto T, Kageyama R, Taga T. 2001. BMP2-mediated alteration in the developmental pathway of fetal mouse brain cells from neurogenesis to astrocytogenesis. Proc Natl Acad Sci USA 98: 5868-5873.
18. Robert ML, Lopez T, Crolla J, Huang S, Owen C, Burvill-Holmes L, Stumper O, Turnpenny PD. 2007. Alagille syndrome with deletion 20p12.2-p12.3 and hypoplastic left heart. Clin Dysmorphol 16: 241-246.
19. Sahoo T, Theisen A, Sanchez-Lara PA, Marble M, Schweitzer DN, Torchia BS, Lamb AN, Bejjani BA, Shaffer LG, Lacassie Y. 2011. Microdeletion 20p12.3 involving BMP2 contributes to syndromic forms of cleft palate. Am J Med Genet Part A 155A: 1646-1653.
20. Sato T, Mikawa S, Sato K. 2010. BMP2 expression in the adult rat brain. J Comp Neurol 518: 4513-4530.
21. Shohat M, Herman V, Melmed S, Neufeld N, Schreck R, Pulst S, Graham JM Jr, Rimoin DL, Korenberg JR. 1991. Deletion of 20p 11.23--pter with normal growth hormone-releasing hormone genes. Am J Med Genet 39: 56-63.
22. Sugiura Y, Araki K, Iemura S, Natsume T, Hoseki J, Nagata K. 2010. Novel thioredoxin-related transmembrane protein TMX4 has reductase activity. J Biol Chem 285: 7135-7142.
23. Urist MR. 1965. Bone: Formation by autoinduction. Science 150: 893-899.
24. Zhang D, Mehler MF, Song Q, Kessler JA. 1998. Development of bone morphogenetic protein receptors in the nervous system and possible roles in regulating trkC expression. J Neurosci 18: 3314-3326.